A groundbreaking treatment to prevent hearing loss in children having cancer treatment is to be used in the NHS (Alamy/PA) Ella Pickover6 days ago A “groundbreaking” drug which helps to ...
has received final draft guidance from the National Institute for Health and Care Excellence (NICE) endorsing PEDMARQSI for the prevention of cisplatin-induced hearing loss in young cancer patients.
has received final draft guidance from the National Institute for Health and Care Excellence (NICE) endorsing PEDMARQSI for the prevention of cisplatin-induced hearing loss in young cancer patients.
A “groundbreaking” drug which helps to prevent hearing loss among children undergoing cancer treatment has been given the green light for NHS use. Chemotherapy drug cisplatin is widely used to treat ...
A “groundbreaking” drug which helps to prevent hearing loss among children undergoing cancer treatment has been given the green light for NHS use. Chemotherapy drug cisplatin is widely used to ...